The researchers have not yet calculated how expensive an oral measles medication would be if
it clears clinical trials in humans.
Not exact matches
Despite encouraging evidence from animal studies that it
clears amyloid from the brain, when it came to
clinical improvements
in human patients the drug proved no better than placebo
in two phase III
clinical trials.
Therapies applying this paradigm to
clear β - amyloid protein (Aβ) plaques and soluble aggregates from patients with Alzheimer's disease (AD) is an extremely active field of research, with multiple active and passive Aβ vaccines currently
in human clinical trials.